4//SEC Filing
BLOCH KATHLEEN P. 4
Accession 0001104659-23-126427
CIK 0001175151other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:32 PM ET
Size
9.1 KB
Accession
0001104659-23-126427
Insider Transaction Report
Form 4
BLOCH KATHLEEN P.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-12-13$1.33/sh+37,594$50,000→ 467,941 total - Purchase
Common Stock Warrant (Right to Buy)
2023-12-13+13,157→ 13,157 totalExercise: $2.00From: 2023-12-13Exp: 2028-12-13→ Common Stock (13,157 underlying)
Footnotes (5)
- [F1]These securities were purchased by the reporting person in the registered direct offering of CytoSorbents Corporation (the "Company"), which closed on December 13, 2023. In the offering, each share of common stock, par value $0.001 per share (the "Common Stock") of the Company was purchased together with an accompanying warrant to purchase up to 0.35 shares of Common Stock, at a combined offering price of $1.33 per share of Common Stock and accompanying warrant
- [F2]Includes: (i) the following restricted stock units ("RSUs") (which vest as to 10,000 RSUs on the first anniversary of the date of grant, and 10,000 RSUs on the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date), and will be settled into Common Stock upon vesting: 20,000 RSUs granted on September 18, 2023;
- [F3](continued from footnote 2) (ii) the following RSUs that will be settled into Common Stock upon a "Change In Control" of the Company, as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 8,800 RSUs granted on March 15, 2018, (b) 15,700 RSUs granted on February 24, 2017, (c) 47,000 RSUs granted on June 7, 2016 and (d) 110,000 RSUs granted on April 8, 2015;
- [F4](continued from footnote 3) (iii) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date), and will be settled into Common Stock upon vesting: 18,500 RSUs granted on August 10, 2022; and
- [F5](continued from footnote 4) (iv) 247,941 shares of Common Stock owned by the reporting person.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001409212
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:32 PM ET
- Size
- 9.1 KB